Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Mar;70(3):1651–1667. doi: 10.1128/jvi.70.3.1651-1667.1996

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

F Gao 1, S G Morrison 1, D L Robertson 1, C L Thornton 1, S Craig 1, G Karlsson 1, J Sodroski 1, M Morgado 1, B Galvao-Castro 1, H von Briesen 1, et al.
PMCID: PMC189989  PMID: 8627686

Abstract

Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been derived almost exclusively from analyses of subtype B viruses, yet such viruses represent only a minority of strains currently spreading worldwide. To generate a more representative panel of genetically diverse envelope genes, we PCR amplified, cloned, and sequenced complete gp160 coding regions of 35 primary (peripheral blood mononuclear cell-propagated) HIV-1 isolates collected at major epicenters of the current AIDS pandemic. Analysis of their deduced amino acid sequences revealed several important differences from prototypic subtype B strains, including changes in the number and distribution of cysteine residues, substantial length differences in hypervariable regions, and premature truncations in the gp41 domain. Moreover, transiently expressed glycoprotein precursor molecules varied considerably in both size and carbohydrate content. Phylogenetic analyses of full-length env sequences indicated that the panel included members of all major sequence subtypes of HIV-1 group M (clades A to G), as well as an intersubtype recombinant (F/B) from an infected individual in Brazil. In addition, all subtype E and three subtype G viruses initially classified on the basis of partial env sequences were found to cluster in subtype A in the 3' half of their gp41 coding region, suggesting that they are also recombinant. The biological activity of PCR-derived env genes was examined in a single-round virus infectivity assay. This analysis identified 20 clones, including 1 from each subtype (or recombinant), which expressed fully functional envelope glycoproteins. One of these, derived from a patient with rapid CD4 cell decline, contained an amino acid substitution in a highly conserved endocytosis signal (Y721C), as mediated virus entry with very poor efficiency, although they did not contain sequence changes predicted to alter protein function. These results indicate that the env genes of primary HIV-1 isolates collected worldwide can vary considerably in their genetic, phylogenetic, and biological properties. The panel of env constructs described here should prove valuable for future structure-function studies of naturally occurring envelope glycoproteins as well as AIDS vaccine development efforts targeted against a broader spectrum of viruses.

Full Text

The Full Text of this article is available as a PDF (846.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abimiku A. G., Stern T. L., Zwandor A., Markham P. D., Calef C., Kyari S., Saxinger W. C., Gallo R. C., Robert-Guroff M., Reitz M. S. Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1581–1583. doi: 10.1089/aid.1994.10.1581. [DOI] [PubMed] [Google Scholar]
  2. Alizon M., Wain-Hobson S., Montagnier L., Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell. 1986 Jul 4;46(1):63–74. doi: 10.1016/0092-8674(86)90860-3. [DOI] [PubMed] [Google Scholar]
  3. Baskar P. V., Ray S. C., Rao R., Quinn T. C., Hildreth J. E., Bollinger R. C. Presence in India of HIV type 1 similar to North American strains. AIDS Res Hum Retroviruses. 1994 Aug;10(8):1039–1041. doi: 10.1089/aid.1994.10.1039. [DOI] [PubMed] [Google Scholar]
  4. Bobkov A., Cheingsong-Popov R., Garaev M., Rzhaninova A., Kaleebu P., Beddows S., Bachmann M. H., Mullins J. I., Louwagie J., Janssens W. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS. 1994 Dec;8(12):1649–1655. doi: 10.1097/00002030-199412000-00002. [DOI] [PubMed] [Google Scholar]
  5. Bobkov A., Garaev M. M., Rzhaninova A., Kaleebu P., Pitman R., Weber J. N., Cheingsong-Popov R. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS. 1994 May;8(5):619–624. [PubMed] [Google Scholar]
  6. Bruce C., Clegg C., Featherstone A., Smith J., Biryahawaho B., Downing R., Oram J. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543–1550. doi: 10.1089/aid.1994.10.1543. [DOI] [PubMed] [Google Scholar]
  7. Charneau P., Borman A. M., Quillent C., Guétard D., Chamaret S., Cohen J., Rémy G., Montagnier L., Clavel F. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology. 1994 Nov 15;205(1):247–253. doi: 10.1006/viro.1994.1640. [DOI] [PubMed] [Google Scholar]
  8. Delwart E. L., Shpaer E. G., Louwagie J., McCutchan F. E., Grez M., Rübsamen-Waigmann H., Mullins J. I. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993 Nov 19;262(5137):1257–1261. doi: 10.1126/science.8235655. [DOI] [PubMed] [Google Scholar]
  9. Dietrich U., Grez M., von Briesen H., Panhans B., Geissendörfer M., Kühnel H., Maniar J., Mahambre G., Becker W. B., Becker M. L. HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS. 1993 Jan;7(1):23–27. doi: 10.1097/00002030-199301000-00003. [DOI] [PubMed] [Google Scholar]
  10. Dubay J. W., Roberts S. J., Hahn B. H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol. 1992 Nov;66(11):6616–6625. doi: 10.1128/jvi.66.11.6616-6625.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dumitrescu O., Kalish M. L., Kliks S. C., Bandea C. I., Levy J. A. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J Infect Dis. 1994 Feb;169(2):281–288. doi: 10.1093/infdis/169.2.281. [DOI] [PubMed] [Google Scholar]
  12. Faulkner D. V., Jurka J. Multiple aligned sequence editor (MASE). Trends Biochem Sci. 1988 Aug;13(8):321–322. doi: 10.1016/0968-0004(88)90129-6. [DOI] [PubMed] [Google Scholar]
  13. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gabuzda D. H., Lever A., Terwilliger E., Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol. 1992 Jun;66(6):3306–3315. doi: 10.1128/jvi.66.6.3306-3315.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gao F., Yue L., Craig S., Thornton C. L., Robertson D. L., McCutchan F. E., Bradac J. A., Sharp P. M., Hahn B. H. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1359–1368. doi: 10.1089/aid.1994.10.1359. [DOI] [PubMed] [Google Scholar]
  16. Gao F., Yue L., Hill S. C., Robertson D. L., Graves A. H., Saag M. S., Shaw G. M., Sharp P. M., Hahn B. H. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses. 1994 May;10(5):625–627. doi: 10.1089/aid.1994.10.625. [DOI] [PubMed] [Google Scholar]
  17. Graham B. S., Wright P. F. Candidate AIDS vaccines. N Engl J Med. 1995 Nov 16;333(20):1331–1339. doi: 10.1056/NEJM199511163332007. [DOI] [PubMed] [Google Scholar]
  18. Grez M., Dietrich U., Balfe P., von Briesen H., Maniar J. K., Mahambre G., Delwart E. L., Mullins J. I., Rübsamen-Waigmann H. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol. 1994 Apr;68(4):2161–2168. doi: 10.1128/jvi.68.4.2161-2168.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gürtler L. G., Hauser P. H., Eberle J., von Brunn A., Knapp S., Zekeng L., Tsague J. M., Kaptue L. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994 Mar;68(3):1581–1585. doi: 10.1128/jvi.68.3.1581-1585.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Haynes B. F. Scientific and social issues of human immunodeficiency virus vaccine development. Science. 1993 May 28;260(5112):1279–1286. doi: 10.1126/science.8493572. [DOI] [PubMed] [Google Scholar]
  21. Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol. 1990 May;64(5):2416–2420. doi: 10.1128/jvi.64.5.2416-2420.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Higgins D. G., Sharp P. M. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci. 1989 Apr;5(2):151–153. doi: 10.1093/bioinformatics/5.2.151. [DOI] [PubMed] [Google Scholar]
  23. Ho D. D., Moudgil T., Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. doi: 10.1056/NEJM198912143212401. [DOI] [PubMed] [Google Scholar]
  24. Hoth D. F., Bolognesi D. P., Corey L., Vermund S. H. NIH conference. HIV vaccine development: a progress report. Ann Intern Med. 1994 Oct 15;121(8):603–611. doi: 10.7326/0003-4819-121-8-199410150-00008. [DOI] [PubMed] [Google Scholar]
  25. Jain M. K., John T. J., Keusch G. T. A review of human immunodeficiency virus infection in India. J Acquir Immune Defic Syndr. 1994 Nov;7(11):1185–1194. [PubMed] [Google Scholar]
  26. Jameel S., Zafrullah M., Ahmad M., Kapoor G. S., Sehgal S. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS. 1995 Jul;9(7):685–690. doi: 10.1097/00002030-199507000-00003. [DOI] [PubMed] [Google Scholar]
  27. Janssens W., Heyndrickx L., Fransen K., Motte J., Peeters M., Nkengasong J. N., Ndumbe P. M., Delaporte E., Perret J. L., Atende C. Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses. 1994 Jul;10(7):877–879. doi: 10.1089/aid.1994.10.877. [DOI] [PubMed] [Google Scholar]
  28. Janssens W., Heyndrickx L., Fransen K., Temmerman M., Leonaers A., Ivens T., Motte J., Piot P., Van der Groen G. Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1577–1579. doi: 10.1089/aid.1994.10.1577. [DOI] [PubMed] [Google Scholar]
  29. Janssens W., Heyndrickx L., Van de Peer Y., Bouckaert A., Fransen K., Motte J., Gershy-Damet G. M., Peeters M., Piot P., van der Groen G. Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS. 1994 Jan;8(1):21–26. doi: 10.1097/00002030-199401000-00004. [DOI] [PubMed] [Google Scholar]
  30. Kaleebu P., Bobkov A., Cheingsong-Popov R., Bieniasz P., Garaev M., Weber J. Identification of HIV-1 subtype G from Uganda. AIDS Res Hum Retroviruses. 1995 May;11(5):657–659. doi: 10.1089/aid.1995.11.657. [DOI] [PubMed] [Google Scholar]
  31. Kalish M. L., Luo C. C., Weniger B. G., Limpakarnjanarat K., Young N., Ou C. Y., Schochetman G. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1573–1575. doi: 10.1089/aid.1994.10.1573. [DOI] [PubMed] [Google Scholar]
  32. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980 Dec;16(2):111–120. doi: 10.1007/BF01731581. [DOI] [PubMed] [Google Scholar]
  33. Korber B. T., Allen E. E., Farmer A. D., Myers G. L. Heterogeneity of HIV-1 and HIV-2. AIDS. 1995;9 (Suppl A):S5–18. [PubMed] [Google Scholar]
  34. Korber B. T., Learn G., Mullins J. I., Hahn B. H., Wolinsky S. Protecting HIV databases. Nature. 1995 Nov 16;378(6554):242–244. doi: 10.1038/378242a0. [DOI] [PubMed] [Google Scholar]
  35. Korber B. T., MacInnes K., Smith R. F., Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol. 1994 Oct;68(10):6730–6744. doi: 10.1128/jvi.68.10.6730-6744.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Korber B. T., Osmanov S., Esparza J., Myers G. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1355–1358. doi: 10.1089/aid.1994.10.1355. [DOI] [PubMed] [Google Scholar]
  37. Kostrikis L. G., Bagdades E., Cao Y., Zhang L., Dimitriou D., Ho D. D. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol. 1995 Oct;69(10):6122–6130. doi: 10.1128/jvi.69.10.6122-6130.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kostrikis L. G., Cao Y., Ngai H., Moore J. P., Ho D. D. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol. 1996 Jan;70(1):445–458. doi: 10.1128/jvi.70.1.445-458.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kuiken C. L., Zwart G., Baan E., Coutinho R. A., van den Hoek J. A., Goudsmit J. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9061–9065. doi: 10.1073/pnas.90.19.9061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kunanusont C., Foy H. M., Kreiss J. K., Rerks-Ngarm S., Phanuphak P., Raktham S., Pau C. P., Young N. L. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 1995 Apr 29;345(8957):1078–1083. doi: 10.1016/s0140-6736(95)90818-8. [DOI] [PubMed] [Google Scholar]
  41. Kusumi K., Conway B., Cunningham S., Berson A., Evans C., Iversen A. K., Colvin D., Gallo M. V., Coutre S., Shpaer E. G. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol. 1992 Feb;66(2):875–885. doi: 10.1128/jvi.66.2.875-885.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. LaBranche C. C., Sauter M. M., Haggarty B. S., Vance P. J., Romano J., Hart T. K., Bugelski P. J., Marsh M., Hoxie J. A. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol. 1995 Sep;69(9):5217–5227. doi: 10.1128/jvi.69.9.5217-5227.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Leitner T., Alaeus A., Marquina S., Lilja E., Lidman K., Albert J. Yet another subtype of HIV type 1? AIDS Res Hum Retroviruses. 1995 Aug;11(8):995–997. doi: 10.1089/aid.1995.11.995. [DOI] [PubMed] [Google Scholar]
  44. Leonard C. K., Spellman M. W., Riddle L., Harris R. J., Thomas J. N., Gregory T. J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem. 1990 Jun 25;265(18):10373–10382. [PubMed] [Google Scholar]
  45. Li W. H., Tanimura M., Sharp P. M. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol. 1988 Jul;5(4):313–330. doi: 10.1093/oxfordjournals.molbev.a040503. [DOI] [PubMed] [Google Scholar]
  46. Li Y., Kappes J. C., Conway J. A., Price R. W., Shaw G. M., Hahn B. H. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug;65(8):3973–3985. doi: 10.1128/jvi.65.8.3973-3985.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lodge R., Göttlinger H., Gabuzda D., Cohen E. A., Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol. 1994 Aug;68(8):4857–4861. doi: 10.1128/jvi.68.8.4857-4861.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Loussert-Ajaka I., Chaix M. L., Korber B., Letourneur F., Gomas E., Allen E., Ly T. D., Brun-Vézinet F., Simon F., Saragosti S. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol. 1995 Sep;69(9):5640–5649. doi: 10.1128/jvi.69.9.5640-5649.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Louwagie J., Janssens W., Mascola J., Heyndrickx L., Hegerich P., van der Groen G., McCutchan F. E., Burke D. S. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol. 1995 Jan;69(1):263–271. doi: 10.1128/jvi.69.1.263-271.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Louwagie J., McCutchan F. E., Peeters M., Brennan T. P., Sanders-Buell E., Eddy G. A., van der Groen G., Fransen K., Gershy-Damet G. M., Deleys R. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 1993 Jun;7(6):769–780. doi: 10.1097/00002030-199306000-00003. [DOI] [PubMed] [Google Scholar]
  51. Lydy S. L., Compans R. W. Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility. J Virol. 1993 Oct;67(10):6289–6294. doi: 10.1128/jvi.67.10.6289-6294.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mammano F., Kondo E., Sodroski J., Bukovsky A., Göttlinger H. G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol. 1995 Jun;69(6):3824–3830. doi: 10.1128/jvi.69.6.3824-3830.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. McCutchan F. E., Hegerich P. A., Brennan T. P., Phanuphak P., Singharaj P., Jugsudee A., Berman P. W., Gray A. M., Fowler A. K., Burke D. S. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses. 1992 Nov;8(11):1887–1895. doi: 10.1089/aid.1992.8.1887. [DOI] [PubMed] [Google Scholar]
  54. McCutchan F. E., Ungar B. L., Hegerich P., Roberts C. R., Fowler A. K., Hira S. K., Perine P. L., Burke D. S. Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr. 1992;5(5):441–449. [PubMed] [Google Scholar]
  55. Miotti P., Canner J., Chiphangwi J., Liomba G., Saah A., Dallabetta G. Preparations for AIDS vaccine evaluations. Rate of new HIV infection in a cohort of women of childbearing age in Malawi. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S239–S241. [PubMed] [Google Scholar]
  56. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol. 1987 Feb;61(2):570–578. doi: 10.1128/jvi.61.2.570-578.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson J., Barbas C. F., 3rd, Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol. 1995 Jan;69(1):101–109. doi: 10.1128/jvi.69.1.101-109.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Moore J. P. HIV vaccines. Back to primary school. Nature. 1995 Jul 13;376(6536):115–115. doi: 10.1038/376115a0. [DOI] [PubMed] [Google Scholar]
  59. Moore J. P., Ho D. D. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS. 1995;9 (Suppl A):S117–S136. [PubMed] [Google Scholar]
  60. Moore J., Anderson R. The WHO and why of HIV vaccine trials. Nature. 1994 Nov 24;372(6504):313–314. doi: 10.1038/372313a0. [DOI] [PubMed] [Google Scholar]
  61. Morgado M. G., Sabino E. C., Shpaer E. G., Bongertz V., Brigido L., Guimaraes M. D., Castilho E. A., Galvão-Castro B., Mullins J. I., Hendry R. M. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses. 1994 May;10(5):569–576. doi: 10.1089/aid.1994.10.569. [DOI] [PubMed] [Google Scholar]
  62. Morrow C. D., Porter D. C., Ansardi D. C., Moldoveanu Z., Fultz P. N. New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S61–S66. [PubMed] [Google Scholar]
  63. Murphy E., Korber B., Georges-Courbot M. C., You B., Pinter A., Cook D., Kieny M. P., Georges A., Mathiot C., Barré-Sinoussi F. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses. 1993 Oct;9(10):997–1006. doi: 10.1089/aid.1993.9.997. [DOI] [PubMed] [Google Scholar]
  64. Myers G. Tenth anniversary perspectives on AIDS. HIV: between past and future. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1317–1324. doi: 10.1089/aid.1994.10.1317. [DOI] [PubMed] [Google Scholar]
  65. Nelson K. E., Beyrer C., Natpratan C., Eiumtrakul S., Celentano D. D., Khamboonruang C. Preparatory studies for possible HIV vaccine trials in northern Thailand. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S243–S246. [PubMed] [Google Scholar]
  66. Nelson K. E., Vlahov D., Galai N., Astemborski J., Solomon L. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S201–S205. [PubMed] [Google Scholar]
  67. Nkengasong J. N., Janssens W., Heyndrickx L., Fransen K., Ndumbe P. M., Motte J., Leonaers A., Ngolle M., Ayuk J., Piot P. Genotypic subtypes of HIV-1 in Cameroon. AIDS. 1994 Oct;8(10):1405–1412. doi: 10.1097/00002030-199410000-00006. [DOI] [PubMed] [Google Scholar]
  68. Olshevsky U., Helseth E., Furman C., Li J., Haseltine W., Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol. 1990 Dec;64(12):5701–5707. doi: 10.1128/jvi.64.12.5701-5707.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Ou C. Y., Takebe Y., Weniger B. G., Luo C. C., Kalish M. L., Auwanit W., Yamazaki S., Gayle H. D., Young N. L., Schochetman G. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet. 1993 May 8;341(8854):1171–1174. doi: 10.1016/0140-6736(93)91001-3. [DOI] [PubMed] [Google Scholar]
  70. Pantaleo G., Demarest J. F., Soudeyns H., Graziosi C., Denis F., Adelsberger J. W., Borrow P., Saag M. S., Shaw G. M., Sekaly R. P. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature. 1994 Aug 11;370(6489):463–467. doi: 10.1038/370463a0. [DOI] [PubMed] [Google Scholar]
  71. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS. 1993 Nov;7 (Suppl 2):S65–S71. doi: 10.1097/00002030-199311002-00014. [DOI] [PubMed] [Google Scholar]
  72. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. doi: 10.1126/science.8096089. [DOI] [PubMed] [Google Scholar]
  73. Porter D. C., Ansardi D. C., Choi W. S., Morrow C. D. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. J Virol. 1993 Jul;67(7):3712–3719. doi: 10.1128/jvi.67.7.3712-3719.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Potts K. E., Kalish M. L., Bandea C. I., Orloff G. M., St Louis M., Brown C., Malanda N., Kavuka M., Schochetman G., Ou C. Y. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res Hum Retroviruses. 1993 Jul;9(7):613–618. doi: 10.1089/aid.1993.9.613. [DOI] [PubMed] [Google Scholar]
  75. Robertson D. L., Hahn B. H., Sharp P. M. Recombination in AIDS viruses. J Mol Evol. 1995 Mar;40(3):249–259. doi: 10.1007/BF00163230. [DOI] [PubMed] [Google Scholar]
  76. Robertson D. L., Sharp P. M., McCutchan F. E., Hahn B. H. Recombination in HIV-1. Nature. 1995 Mar 9;374(6518):124–126. doi: 10.1038/374124b0. [DOI] [PubMed] [Google Scholar]
  77. Rowell J. F., Stanhope P. E., Siliciano R. F. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol. 1995 Jul 1;155(1):473–488. [PubMed] [Google Scholar]
  78. Ruff A. J., Coberly J., Halsey N. A., Boulos R., Desormeaux J., Burnley A., Joseph D. J., McBrien M., Quinn T., Losikoff P. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr. 1994 Jan;7(1):68–73. [PubMed] [Google Scholar]
  79. Rübsamen-Waigmann H., von Briesen H., Holmes H., Björndal A., Korber B., Esser R., Ranjbar S., Tomlinson P., Galvao-Castro B., Karita E. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1401–1408. doi: 10.1089/aid.1994.10.1401. [DOI] [PubMed] [Google Scholar]
  80. Sabino E. C., Shpaer E. G., Morgado M. G., Korber B. T., Diaz R. S., Bongertz V., Cavalcante S., Galvão-Castro B., Mullins J. I., Mayer A. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol. 1994 Oct;68(10):6340–6346. doi: 10.1128/jvi.68.10.6340-6346.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987 Jul;4(4):406–425. doi: 10.1093/oxfordjournals.molbev.a040454. [DOI] [PubMed] [Google Scholar]
  82. Sharp P. M., Robertson D. L., Hahn B. H. Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci. 1995 Jul 29;349(1327):41–47. doi: 10.1098/rstb.1995.0089. [DOI] [PubMed] [Google Scholar]
  83. Smith R. F., Smith T. F. Automatic generation of primary sequence patterns from sets of related protein sequences. Proc Natl Acad Sci U S A. 1990 Jan;87(1):118–122. doi: 10.1073/pnas.87.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Smith R. F., Smith T. F. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng. 1992 Jan;5(1):35–41. doi: 10.1093/protein/5.1.35. [DOI] [PubMed] [Google Scholar]
  85. Spire B., Sire J., Zachar V., Rey F., Barré-Sinoussi F., Galibert F., Hampe A., Chermann J. C. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene. 1989 Sep 30;81(2):275–284. doi: 10.1016/0378-1119(89)90188-1. [DOI] [PubMed] [Google Scholar]
  86. Sullivan N., Sun Y., Li J., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol. 1995 Jul;69(7):4413–4422. doi: 10.1128/jvi.69.7.4413-4422.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Thompson J. D., Higgins D. G., Gibson T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994 Nov 11;22(22):4673–4680. doi: 10.1093/nar/22.22.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Vanden Haesevelde M., Decourt J. L., De Leys R. J., Vanderborght B., van der Groen G., van Heuverswijn H., Saman E. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol. 1994 Mar;68(3):1586–1596. doi: 10.1128/jvi.68.3.1586-1596.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Warren J. T., Dolatshahi M. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol. 1994 Feb-May;23(2-3):184–225. doi: 10.1111/j.1600-0684.1994.tb00120.x. [DOI] [PubMed] [Google Scholar]
  90. Wrin T., Nunberg J. H. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals. AIDS. 1994 Nov;8(11):1622–1623. doi: 10.1097/00002030-199411000-00017. [DOI] [PubMed] [Google Scholar]
  91. Wyatt R., Moore J., Accola M., Desjardin E., Robinson J., Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol. 1995 Sep;69(9):5723–5733. doi: 10.1128/jvi.69.9.5723-5733.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Yahi N., Fantini J., Hirsch I., Chermann J. C. Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1. Arch Virol. 1992;125(1-4):287–298. doi: 10.1007/BF01309645. [DOI] [PubMed] [Google Scholar]
  93. Yu X., Yuan X., McLane M. F., Lee T. H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol. 1993 Jan;67(1):213–221. doi: 10.1128/jvi.67.1.213-221.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES